Mar 20, 2026 | Article
For decades, Africa has often been portrayed as a continent trying to “catch up” with the rest of the world in science, healthcare, and innovation. But a growing movement among African scientists, institutions, and global partners suggests a different narrative...
Mar 19, 2026 | Blog
Africa is still too often brought into drug and vaccine development late, most commonly during Phase III, post-marketing, or implementation studies. Scientifically, that is a weak model. Phase I and II studies are where development programmes establish core...
Mar 18, 2026 | Blog
Women remain underrepresented in Africa’s research workforce overall, and they are even less visible in senior academic and scientific leadership roles. UNESCO’s latest figures show that women account for about 32% of researchers in sub-Saharan Africa, although...
Mar 13, 2026 | Blog
Ethics in clinical research has never been a matter of paperwork alone. Yet in practice, ethical quality is still too often judged by whether the right forms were signed, the right approvals were secured, and the protocol was followed on paper. Across African research...
Mar 11, 2026 | Blog
Across Africa, something subtle but important is changing in the way leaders talk about health. For many years, health systems across the continent were largely framed through the lens of global solidarity: donor programs, development assistance, and externally...
Mar 11, 2026 | Blog
When we discuss the advancement of clinical trials in Africa, the conversation often gravitates toward infrastructure: genomic sequencing capacity, biobanking facilities, or electronic data capture systems. While these physical assets are vital, there is an equally...
Mar 10, 2026 | Blog
Global health rhetoric is rich with good intentions. Few terms have been as enduring or as poorly interrogated, as “capacity building”. For decades, it has served as a justification for donor spending, a line item in pharmaceutical industry corporate...
Mar 5, 2026 | Blog
On January 14, 2026, the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released ten guiding principles for Good AI Practice (GAIP) in drug development (1). This landmark collaboration signals that artificial...
Feb 27, 2026 | Blog
What if clinical trials were no longer the bottleneck of drug development? For decades, innovation has followed a familiar trajectory. Discovery has advanced rapidly within highly specialized research environments. Development has proceeded through increasingly...
Feb 25, 2026 | Blog
For decades, segments of the global pharmaceutical industry have approached Africa with hesitation. The dominant narrative has framed the continent as a “challenging frontier”—a region burdened by logistical constraints, uneven infrastructure, and opaque...
